Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2020-07-23 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended March 31, 2020, prepared pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed financial data on transactions with related parties, including remuneration, dividends, advances, commissions, and CSR contributions. The document is substantive, with actual financial figures and descriptions of relationships and transactions. It is not merely an announcement or a certification but a detailed disclosure report. Such disclosures are typically part of regulatory compliance filings but given the detailed financial data and the nature of the content, it fits best under Regulatory Filings (RNS) as it does not constitute a full financial report like an Annual or Interim Report, nor is it a standalone audit or management report. It is a regulatory disclosure mandated by SEBI.
2020-07-23 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2020. It is a confirmation certificate from the Registrar and Share Transfer Agent (RTA) and is addressed to stock exchanges. The document is short (1624 characters) and serves as a regulatory compliance filing rather than a financial report or detailed disclosure. It does not contain financial statements, management discussion, or detailed report content. It is primarily a regulatory filing confirming compliance with a specific regulation. Therefore, it fits best under Regulatory Filings (RNS).
2020-07-13 English
Trading Window
Regulatory Filings
2020-06-30 English
Financial Result Updates
Regulatory Filings
2020-06-25 English
Outcome of Board Meeting
Regulatory Filings
2020-06-25 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) notifying about an upcoming Board Meeting scheduled for June 25, 2020. The purpose of the meeting is to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2020. It also mentions the closure of the trading window for insiders in compliance with SEBI regulations. The document does not contain the financial results themselves but is an announcement of the meeting where these results will be approved. The document length is short (2445 characters), and it serves as an intimation rather than the actual financial report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to exchanges about board meetings and trading window closure, rather than a full financial report or earnings release.
2020-06-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.